A Study to Investigate Safety and Tolerability, Pharmacokinetics and Pharmacodynamics of JNJ-55375515 in Healthy Male Participants
Clinical trial NCT03405441 · COMPLETED
Trial details
- NCT number
- NCT03405441
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-01-02
- Primary completion
- 2018-09-04
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.